Data room / Run 1, stage 1: the nine reviews

Institutional investor

Review, written by the institutional investor reviewer, 4,750 words, about 21 min to read

run-1/reviews/investor.md Open the file as written

EQUITY FLOW — INVESTOR / CREDIT DILIGENCE REVIEW

Reviewer: senior credit + venture/PE lens (adversarial). Date: 2026-08-01. Materials: public/equity-flow.html (investor section, full copy reviewed via plain-text extraction) and disclosures/equity-flow-invention-disclosure.txt (all 39 sections, read in full). Framing per mandate: assume the product has already failed; explain why.


PART A — MARKETING vs. SPEC: CLAIM-BY-CLAIM DIVERGENCE AUDIT

Each item: page claim -> what the spec actually delivers -> severity.

A1. "Natural demand — 50M+ locked-in homeowners, no competing product." (For-the-investor bullets) The same page contains two full comparison tables against competing products (Hometap, Unison, Point, HECM tenure option). HECM tenure delivers monthly cash flow from home equity today; HEIs deliver equity monetization today; HELOCs deliver liquidity today. "No competing product" is false on the page's own evidence. Severity: MAJOR (misrepresentation in an investor solicitation).

A2. "Downside capped at capital already disbursed" / "Capital preserved. Full return of deployed capital from closing proceeds even with zero appreciation" / Equity Shield "Bear case return 1.0x guaranteed." Spec Flow 4: if proceeds are insufficient, losses flow in reverse priority — homeowner equity first, then investor appreciation share, THEN investor capital return, and the claim is non-recourse. Spec Event 4: senior foreclosure EXTINGUISHES the interest. Spec Section 33: short sale — investor absorbs any shortfall. So the capital return is not a floor; it is a junior, non-recourse residual claim. "Capital preserved" is true only in the benign sale path. Severity: CRITICAL (the central risk representation to investors is wrong).

A3. "Homeowner ... nets $690K at closing ($879K sale minus $190K to investor)." Spec Section 19 for the identical deal: net to homeowner at closing is ~$339,950 after the ~$350,000 mortgage payoff the page silently drops. The page's own downside example DOES deduct the mortgage ("walks away with ~$158K") — the mortgage is omitted only where it flatters the base case. The "$816K total lifetime value" figure inherits the same omission, and the "cost of unlocking: ~$64K" figure excludes the 2-3% origination fee (~$3,150) and all transaction fees, and ignores time value entirely. Severity: MAJOR (internally inconsistent, cherry-picked arithmetic; also a homeowner-side UDAAP problem).

A4. Secondary market certainty language: "Duration risk stops being a problem and becomes the product you sell upstream" / "the originating fund ... sells the seasoned position to an insurance company or pension fund. The originator crystallizes IRR and recycles capital. Done." / comparison table row "Secondary market: Seasoned ride-along positions sold to insurers/pensions" (present tense, as fact). Spec Section 8, CRITICAL RISK ACKNOWLEDGMENT: "The secondary market for Equity Flow ride-along positions does not exist today." The page discloses this only inside one collapsed FAQ answer ("The honest risk"), while stating it as accomplished fact in at least four other places, including the answer to the existential "what if the homeowner never sells" question. Severity: CRITICAL (the fund's entire liquidity thesis is presented as existing when the spec concedes it is hypothetical).

A5. Equity Shield "guarantees a minimum 1.0x capital return" / "1.0x guaranteed." Spec Section 17: "This concept requires further development and actuarial modeling before launch." The page's own footnote admits it is "a product concept under development" — after headlining the word "guaranteed." There is no guarantor balance sheet, no reserve seeded at launch, and my math (Part C) shows the proposed 50-75bps fee accumulates ~2.2% of peak deployed capital over 7 years — an order of magnitude short of a credible 1.0x floor in a correction. "If markets are fine, excess reserve is retained by noteworth" means the platform keeps the premium and bears the tail with no capital: an unfunded put. Whether selling a capital-floor guarantee for a fee is financial guaranty insurance requiring an insurance license: STATE-DEPENDENT, and unanalyzed in the spec. Severity: CRITICAL ("guaranteed" language on an unfunded, unlicensed, undeveloped concept).

A6. "~11% IRR" / "1.50x." Arithmetically verified (11.7% — Part B) but ONLY as a gross, deal-level IRR conditional on (i) 5%/yr HPA — above the long-run US nominal average of ~3.5-4.5% — and (ii) an organic exit at exactly year 7 by a homeowner the underwriting box deliberately screens for unwillingness to sell. No net-of-fees figure appears anywhere. The Equity Shield section on the same page uses "Expected IRR 8.5%" for apparently the same portfolio — the page contradicts itself on its headline return. Severity: MAJOR.

A7. "Title-secured. Repayment comes from closing escrow — investor gets paid before the homeowner." Spec Section 34: the recorded interest is "NOT a lien in the traditional sense," carries no foreclosure right and no power of sale; enforcement is limited to waiting for a voluntary exit or petitioning a court. Also, waterfall Priority 5 places broker commissions and transfer taxes BEHIND the investor's appreciation share — commercially unworkable (agents are paid off the top at closing under the listing agreement); in thin-equity closings the stated priority will not survive contact with a real escrow. Severity: MAJOR.

A8. Homeowner-facing "You're never forced to sell or settle ... you decide when to sell, if ever" vs. spec Sections 32/37: loss of owner-occupancy >12 months, unauthorized encumbrance, or repeated defaults let the investor "demand settlement or petition for court-ordered sale"; heirs face a probate-court sale petition after 12 months. Either the marketing is false, or the investor's enforcement remedies are cosmetic. Both readings are bad: one is a consumer misrepresentation, the other guts recovery. Severity: MAJOR.

A9. Market pause: page says "If the market recovers, payments resume" and frames the pause purely as homeowner protection. Spec Flow 3a adds the load-bearing sentence the page omits: "Paused months do NOT extend the term or reduce the appreciation share." A homeowner paused for 30 of 84 months receives $81K instead of $126K yet still owes the full 25% share; equivalently the investor buys the same appreciation strip for less money. The pause is a one-sided investor option (quarterly, investor-selected AVM; homeowner pays for the appraisal to dispute) marketed as a homeowner benefit. Severity: MAJOR (disclosure gap + moral hazard, below).

A10. The downside-case example contradicts the pause mechanism. Both the page and spec Section 20 show 36 full months of disbursements ($54K) while the home declines monotonically ~10% below the enrollment value — a path on which the quarterly AVM check should have paused payments within months 1-6, capping deployment near $4.5-9K. Either (a) the pause doesn't actually work (AVM lag/dispute friction), or (b) the flagship downside example is wrong by ~10x on capital at risk. Severity: MAJOR (the two headline safety mechanisms are mutually inconsistent as documented).

A11. Ratchet arithmetic inconsistency: the page says a year-12 homeowner "still retains 55%+ of their appreciation"; the mechanics (25% + 5 ride-along years = 30% investor share) give 70%. Also under-disclosed: the ratchet re-prices ALL appreciation from enrollment (including the active-term years), not just post-term growth — a retroactive repricing framed as "duration compensation." Severity: MINOR (sloppiness) / MAJOR (retroactivity disclosure).

A12. "Structured as equity agreement — lighter regulatory path" / spec Section 25 ("not subject to TILA ... RESPA ... usury"). Tags: that HEI-type contracts avoid TILA/RESPA/usury is at best a LIKELY INTERPRETATION historically and is now STATE-DEPENDENT — several states (e.g., Connecticut, Maryland, Washington) have moved HEI contracts under mortgage/consumer-loan licensing regimes, and the CFPB has publicly signaled that home equity contracts may be mortgages under Reg Z. Recharacterization as an equitable mortgage by a state court (with usury consequences at an 11.7%+ implied APR) is STATE-DEPENDENT. The spec partially concedes this; the page does not. Severity: MAJOR.

A13. "This is established real estate law in all 50 states" (enforcement FAQ). Recording + escrow payoff mechanics: SETTLED LAW. Enforceability of THIS instrument — an indefinite-duration equitable interest in future appreciation with a unilateral ratchet, no maturity, surviving 25+ years dormant — against marketable-title acts, dormancy statutes, restraint-on-alienation and unconscionability doctrines: STATE-DEPENDENT / AMBIGUOUS. The blanket claim overreaches. Severity: MAJOR.

A14. Tax claims. "This mirrors how existing HEI products are treated": there is no IRS ruling or published guidance blessing prepaid-forward/open-transaction treatment even for lump-sum HEIs — LIKELY INTERPRETATION at best. Extending it to an 84-payment monthly stream: AMBIGUOUS trending SPECULATIVE (the spec itself calls it the "primary tax vulnerability" and conditions launch on a tax opinion/PLR). "The 1.0x structure eliminates the interest-vs-gains ambiguity entirely": overclaim — recharacterization of the whole arrangement as a loan survives the removal of the premium; tag AMBIGUOUS. Investor-side "appreciation share is likely capital gains": LIKELY INTERPRETATION. Section 121 interaction as described: AMBIGUOUS (depends on how the investor's share is characterized against amount realized/basis). Spec's Chapter 13 position ("not subject to modification ... because it is not a debt"): SPECULATIVE, and the spec admits it "requires validation by counsel." Severity: CRITICAL at product level (an adverse answer destroys the consumer proposition and therefore origination volume).

A15. Origination fee double counting: the page books the 2-3% fee as investor "Revenue stream 2," while spec Sections 18/36 say the same fee "covers origination costs, underwriting, legal review, and platform operating expenses" and is paid to "Investor / fund manager." It cannot be both LP revenue and the opex budget. Also undisclosed: the fee is charged on PROJECTED disbursements, so a homeowner paused or exiting early pays the full fee on money never received (downside case: $3,150 on $54K received = 5.8% effective). Severity: MAJOR.

A16. Term inconsistency: homeowner-facing tool offers 10/15/20/30-year payment terms at a 75% payout rate; investor-facing spec standardizes 5-10 years (7 standard). The two audiences are being shown different products. Severity: MINOR-MAJOR (reconcile before anyone signs anything).

A17. "Collateralized by real property — no tenants, no management." The covenant stack (Sections 30/37) requires the investor to monitor occupancy, insurance, taxes, maintenance, liens, and notices across thousands of consumer counterparties for potentially decades, with certified-mail cure machinery. This is a servicing-intensive consumer asset, not passive paper. Severity: MINOR (but feeds unit economics).


PART B — INDEPENDENT REBUILD OF DEAL ECONOMICS (extra task 2)

Method: monthly cash flows, $1,500/mo out for min(exit, 84) months; at exit, inflow = capital returned (1.0x of disbursed) + ratcheted share of appreciation on a $625,000 enrollment value (share = 25% through year 7, +1 pt/yr after, cap 50%). IRR = monthly IRR annualized. Python, bisection solver.

B1. Base case (exit yr 7, 5% HPA): deployed $126,000; capital return $126,000; appreciation share $63,609; total $189,609; multiple 1.50x; IRR = 11.7%. VERDICT ON THE CLAIM: the "~11% / 1.50x" arithmetic is verified as a GROSS, deal-level number under its own assumptions. The assumptions are the problem (below).

B2. IRR sensitivity grid (gross, deal-level, %; no pauses, no defaults, no fees):

exit yr | 0% HPA | 3% HPA | 5% HPA | multiple @5% (share, deployed) 2 | 0.0 | 26.5 | 43.5 | 1.44x (25%, $36K) 5 | 0.0 | 10.0 | 16.2 | 1.48x (25%, $90K) 7 | 0.0 | 7.2 | 11.7 | 1.50x (25%, $126K) 10 | 0.0 | 6.1 | 9.9 | 1.87x (28%, $126K) 15 | 0.0 | 5.8 | 9.1 | 2.77x (33%, $126K) 25 | 0.0 | 5.7 | 8.7 | 6.09x (43%, $126K)

Read-throughs:

  • At the long-run US nominal HPA of ~3-4%, the deal NEVER clears an 8% cost of capital at any realistic exit year. Break-even HPA for 8% gross IRR at a year-7 exit is 3.34%/yr; for the claimed 11%, 4.67%/yr; for a 15% venture-style gross, 6.5%/yr. The pitch's 5% HPA assumption IS the return.
  • At 0% HPA the IRR is exactly 0% nominal (negative real) for up to 25 years. The 1.0x structure means every flat or down deal is dead capital, not a coupon.
  • IRR decays monotonically after year 7 (11.7% -> 9.9% -> 9.1% -> 8.7% at 5% HPA; 7.2% -> 5.7% at 3%). The +1%/yr ratchet grows the MULTIPLE but does not preserve the IRR — duration is not compensated, only slowed. The ultra-long-hold example's "3.33x" is IRR ~5.7-8.7% dressed up as a big multiple.
  • High-IRR cells (year-2 exit at 26-44%) are dollar-trivial ($16-28K of profit) and are exactly the deals the "lock-in score" screens OUT.

B3. The structural contradiction the base case hides. Underwriting requires homeowners with deep rate locks, "no near-term sale plans," and a high "holding propensity" score. The base case then assumes those same homeowners sell at exactly year 7. If they behave as underwritten (median US tenure now ~12-13 years; these are selected stayers), the realized column is year 10-25, i.e., 5.7-9.9% gross — before fees, pauses, defaults, and liquidity discounts. The 11% IRR requires the customer to do the thing the product selects them not to do.

B4. Secondary-sale rescue, modeled. If no organic exit at year 7, the originator sells to a Tier 2 buyer at the PV of the expected payoff (assume expected organic exit year 15, so an 8-year Tier 2 hold, share ratcheted to 33%):

HPA 3%: yr-15 payoff $241K -> at 6/8/10% Tier 2 discount rate, price $151K/$130K/$112K -> originator IRR 5.3% / 1.0% / -3.3% HPA 5%: yr-15 payoff $349K -> price $219K/$188K/$163K -> originator IRR 15.8% / 11.5% / 7.3%

So the "crystallize IRR at year 7-8" story only reproduces ~11% if HPA runs at 5% AND a buyer that does not yet exist prices this novel, uncoupled, no-maturity paper at an 8% discount rate with no novelty/illiquidity haircut. At normal HPA and any realistic risk premium, the secondary sale locks in roughly T-bill-or-worse returns.

B5. Net to LPs. Applying a standard 2%/20% load to the base case (mgmt fee ~$17.6K per deal-equivalent over 7 yrs, carry ~$9.2K): net LP IRR ~7.4% — in the best-case cell of the grid, before pause drag, credit losses, and unsold-tail discounts. An illiquid, unproven, first-time-manager structure competing for LP capital against liquid credit yielding 6-8% needs 15%+ net. It cannot get there on these terms. (No management fee or carry is specified anywhere in the 39-section spec — the fund's own economics are literally undefined; the 11% is gross of a fee structure that hasn't been written.)

B6. Homeowner cost mirror (context): the homeowner's APR-equivalent in the base case is the same 11.7% (plus ~0.5-0.6% for the origination fee) — i.e., the product is economically an ~12%+ effective-cost draw. Cheaper alternatives (HELOC at prime+~1, ~8-9% in 2026) exist for most qualified borrowers, which caps conversion among exactly the high-FICO, low-LTV homeowners the box requires.


PART C — FINDINGS BY CATEGORY

MARKET

M1. Gross TAM is real but the pitch conflates it with SAM. ~50M mortgaged owner-occupants below-market-rate is directionally consistent with FHFA lock-in research. Apply the spec's own box (rate spread >=2.5%, >= $50K appreciation, >=20% equity, >= $300K value, post-deployment CLTV <=80%, owner-occupied, clean 12-month pay history, stated intent to stay): plausibly 8-15M households. Apply behavior: willingness to record an open-ended encumbrance on the family home for ~$1,500/mo — the entire incumbent HEI industry, after ~15 years and heavy marketing spend, originates roughly $2-3B/yr TOTAL. Realistic obtainable share for a new entrant: low thousands of deals/yr at maturity, not millions. Severity: MAJOR (TAM overstated by ~2 orders of magnitude as a serviceable figure).

M2. The TAM is a melting ice cube. The product's premise is the 2020-22 rate-lock anomaly. Every 50bp decline in market rates shrinks the >=2.5%-spread pool nonlinearly and (via the spec's own rate-and-term subordination carve-out) restores homeowner mobility. A product whose origination funnel requires rates to stay high, whose exits require homeowners to move, and whose collateral appreciation historically correlates with FALLING rates is internally short itself. Severity: CRITICAL for a 10-15 year fund life.

M3. Competitive response: Hometap/Point/Unison can replicate the only novel features (monthly disbursement schedule; deferred settlement) as contract amendments — they already own the origination stack, state licensing, servicing, and institutional capital (Bain, Redwood, Palisades). A common-law trademark and an invention disclosure provide no exclusivity; financial-structure patents post-Alice: LIKELY INTERPRETATION that no defensible patent issues. Expected copy time if the concept works: 2-4 quarters. Severity: MAJOR.

UNIT ECONOMICS

U1. Origination fee does not cover origination. $3,150/deal (2.5% x $126K) must cover CAC, underwriting, legal doc prep, QC, and platform allocation. Realistic fully loaded cost for a novel, trust-intensive consumer product closing in 30-45 days with appraisal/title/notary logistics: $4,000-$8,000+/deal at sub-scale (consumer-mortgage CAC alone runs $1,500-$3,000). The fund subsidizes every origination; the spec has no other platform revenue except the speculative Equity Shield float. Severity: MAJOR.

U2. Platform break-even requires implausible volume. At ~$3K/deal contribution and a lean $3-5M opex, break-even is 1,000-1,700 deals/yr = $130-215M/yr of NEW 7-year disbursement commitments — 3-4x the entire proposed $50M proof-of-concept fund, every year. Severity: MAJOR.

U3. Return threshold: gross deal IRR falls below an 8% cost of capital whenever HPA < 3.34% (year-7 exit) and below ~5.8-6.1% whenever exits slip to years 10-15 at 3% HPA (Part B). The base case only works in an above-trend housing decade with on-schedule exits. Severity: CRITICAL.

CAPITAL STRUCTURE

C1. The fund writes binding 84-month forward commitments (Section 31: BINDING, with forfeiture remedies) against committed LP capital, with zero interim income and distributions back-loaded to years 7-15+. This is the deepest J-curve in consumer finance: 100% of capital out before the first dollar back. LP base that tolerates this while accepting ~7% net expected: does not exist. Severity: CRITICAL.

C2. Doom-loop clause: if the fund misses 3 disbursements in 12 months, each affected homeowner may terminate WITH FORFEITURE OF THE APPRECIATION SHARE (the only return driver), leaving the fund a 0%-yield receivable with no maturity. A funding hiccup (LP default, failed Fund II, recycling shortfall) therefore converts the entire book from 1.5x-hoped to 1.0x-capped-someday. Fund distress is self-amplifying by contract design. Severity: CRITICAL.

C3. Market pause does NOT release capital. Paused deals can resume, so Section 39(m) reserves must be held against full remaining commitments. In a correction with 20-40% of the book paused, the fund holds idle cash (IRR drag) against contingent resumption while its exit values are simultaneously falling — negative convexity on both sides of the balance sheet. Required reserve: effectively 100% of undisbursed commitments; no leverage or reinvestment relief is specified. Severity: MAJOR.

C4. Realistic fund life with no secondary market: originate years 1-3 -> disburse through year 10 -> organic exits (adversely selected stayers) years 12-25. That is a 15-20+ year vehicle sold as PE-style 7-10. The spec concedes this in one sentence; the fund docs implied by the marketing do not. Severity: CRITICAL absent a proven secondary bid.

C5. 1.0x floor + non-recourse junior position = asymmetric loss severity at portfolio level: winners pay ~25-30% of appreciation with a long lag; losers return 0% nominal for years or take principal hits in foreclosure/short-sale/bankruptcy tails, and all deals within a metro are correlated to one housing factor. There is no coupon, spread, or premium anywhere in the structure to absorb ANY credit loss. Portfolio expected return = HPA beta minus losses minus fees, full stop. Severity: CRITICAL.

ADVERSE SELECTION / MORAL HAZARD

AS1. Cash-need selection: households that will encumber their home for $1,500/mo skew financially stressed relative to the pristine-on-paper box; stress predicts first-mortgage delinquency, and senior foreclosure is the one path that wipes the position entirely. The underwriting box screens documents, not trajectories. Severity: MAJOR.

AS2. Mobility misrepresentation is free: "no intent to sell within 12 months" is expressly non-binding (Section 39(i)). Homeowners with private near-term-sale knowledge in flat markets receive an interest-free advance (0% IRR to fund). The proposed mitigant (3-year minimum term with "slightly higher share") is a "can include," not a term. Severity: MAJOR.

AS3. The homeowner holds all the timing options: (i) sell/settle when appreciation is ~zero -> free money; (ii) hold when appreciation is rich (delaying and diluting investor IRR — ratchet undercompensates, Part B2); (iii) Event 9 voluntary buyout at CURRENT appraised value at any time — a free American call to terminate at a market trough (buy out cheap after a dip, keep the recovery). The investor holds no symmetric option and no foreclosure right. Severity: CRITICAL in aggregate — the contract is short a straddle to its own counterparty.

AS4. Pause mechanism moral hazard runs TOWARD the investor: investor selects the AVM/index, runs the quarterly check, stops deploying into falling markets, does not extend the term, and keeps the full share — while the homeowner bears 100% of their own home-value downside and loses the income exactly in recessions. Fine for the investor economically, but it is marketed to both audiences as homeowner protection; when this asymmetry is litigated or reported on, expect recharacterization ammunition ("lender behavior") and reputational damage that kills the origination funnel. Severity: MAJOR.

AS5. Renovation exclusion: cost-documented improvements are subtracted from shared appreciation at exit — verified by receipts up to 25 years old, submitted by the counterparty who benefits, with related-party contractor and invoice-inflation vectors and no audit mechanism specified. Every $100K of accepted receipts costs the investor $25-50K of share. Severity: MAJOR at scale.

DEFAULT / RECOVERY

D1. Recovery in senior foreclosure: interest extinguished (Event 4 — SETTLED LAW for junior interests); recovery limited to surplus-proceeds claims, which after arrears, fees, and auction discounts are typically minimal. Expected recovery on deployed capital in this path: 0-50%, mode near 0. Severity: MAJOR (probability-weighted CRITICAL in a recession vintage).

D2. Bankruptcy. Chapter 7: trustee/debtor incentives to attack the recorded interest as (a) a disguised loan/equitable mortgage (STATE-DEPENDENT), (b) an executory contract subject to rejection (AMBIGUOUS — no case law on this instrument), or (c) avoidable if the memorandum recording is defective (strong-arm powers — SETTLED LAW mechanism, fact-dependent application). Chapter 13: if recharacterized as a wholly-unsecured junior lien, strip-off is available (SETTLED LAW for junior mortgages; application here AMBIGUOUS). The spec's position that the claim is untouchable "because it is not a debt" is SPECULATIVE and self-servingly circular — the same "not debt" argument is what a debtor will use to call it an unsecured contingent contract claim. Loss severity in contested bankruptcy: 50-100% plus $50-150K legal per case. Severity: CRITICAL (unpriced tail on every deal).

D3. Enforcement against a living, occupying homeowner: no foreclosure right, no power of sale; remedies are demand letters, then a court petition to force sale of an owner-occupied primary residence over covenant breaches (occupancy, insurance, unauthorized lien). Timeline 18-36 months; homestead protections STATE-DEPENDENT; press coverage guaranteed ("startup evicts family"). In practice the fund will not enforce, meaning the covenants are decorative and Loss-Given-Default rises accordingly. Severity: MAJOR.

D4. Insurance mechanics: naming an equity claimant as additional insured/loss payee is nonstandard; carriers routinely refuse non-lender loss payees. If refused, the property-destruction waterfall (Event 5) is unsecured hope. Practice-dependent; unresolved in spec. Severity: MINOR-MAJOR.

SECONDARY MARKET

S1. Evidence for the insurer bid: none. The analogies offered (life settlements, longevity swaps, HECM tails) all pay defined or bounded cash flows with actuarial maturities. A dormant ride-along position pays NOTHING — no coupon, no maturity, no control over timing — and its value is a levered bet on one house's price and one household's mobility. For an insurer this is equity-real-estate-like RBC treatment (high capital charge), not bond-bucket paper, and it is negative-carry. Life settlements took ~15 years, rating-agency frameworks, and scandal cleanup to institutionalize. Severity: CRITICAL — the thesis is asserted, not evidenced, and the spec admits the market "does not exist today."

S2. Seasoning requirement: institutional buyers will want 5-10 years of performance data spanning at least one full housing drawdown, audited exit distributions, resolved tax characterization, and resolved bankruptcy treatment — i.e., the market cannot exist before roughly year 8-12 of the platform's life, which is AFTER the first fund needs it. Chicken-and-egg by construction. Severity: CRITICAL.

S3. Pricing: modeled in Part B4. At 3% HPA and an 8% Tier 2 discount rate, the year-7 sale delivers ~1% originator IRR; add a plausible 10-20% novelty/illiquidity haircut and the "crystallized IRR" is negative at trend HPA. Expect Tier 2 bids, if any, at 20-40% discounts to actuarial EV until a decade of data exists. Severity: CRITICAL.

S4. Minimum viable pool: insurers transact in $100-250M+ seasoned pools with a servicer, trustee, legal opinions, and diligence data-tape infrastructure — none of which is specified or budgeted anywhere in the 39 sections. Severity: MAJOR.

S5. If no market by years 7-8 (base case, per S1-S2): fund life extends to 15-20+ years, IRR decays per the grid to 5.7-9.9%, LPs are trapped, and the manager's only lever is fire-selling the tail at deep discounts — which crystallizes the bad column of Part B4. The spec's honest sentence ("first-mover risk ... where the alpha is") is the correct label for what is actually the fund's most probable terminal state. Severity: CRITICAL.

DEFENSIBILITY

DF1. No patent, no exclusive data, no licensing moat, no capital-cost advantage, no brand. The "innovations" (payment scheduling, deferred settlement, a ratchet) are contract clauses — copyable by any incumbent in one drafting cycle, and incumbents have every advantage in capital, compliance, and funnel. Severity: MAJOR.

DF2. Noteworth distribution = free calculators. Anyone with homeowner data (Zillow, Rocket, Redfin, every servicer with an app) can replicate the "education-first funnel" with vastly better traffic and pre-existing trust. Servicers additionally know the exact rate, balance, and payment history — a strictly superior lock-in score. Severity: MAJOR.

DF3. First-mover here is a liability: the entrant pays to educate the market, absorbs the first CFPB/state-AG actions and the first adverse tax ruling, and then watches capitalized incumbents ship the de-risked copy. Severity: MAJOR.

OTHER

O1. Fund-manager economics are absent from the spec (no management fee, no carry, no servicing fee is defined anywhere), so every quoted IRR is gross of an unwritten fee stack; simultaneously the origination fee is double-promised (A15). The business model of the management company is undefined. Severity: MAJOR.

O2. Securities: LP interests in the fund are securities (SETTLED LAW). A public webpage pitching deal-level IRRs, "guaranteed" floors, and "no competing product" is general-solicitation material; if the fund raises under 506(b), this page is a problem, and under 506(c) its accuracy standards still apply (misrepresentation exposure per A1-A5). Classification of Equity Shield (insurance? swap? security?): AMBIGUOUS. Severity: MAJOR (securities counsel's lane; flagged here because the page IS the offering narrative).

O3. Internal inconsistencies catalog (page vs page, page vs spec): 11% vs 8.5% expected IRR; $690K vs $340K net; 70% vs "55%+" retained at year 12; 36-month downside deployment vs pause mechanics; 10-30yr homeowner terms vs 7yr investor term; "never forced to settle" vs court-ordered-sale remedies; "no competing product" vs two competitor tables. A diligence-grade reader finds all of these in one sitting — as I just did. Credibility damage alone would end an institutional process. Severity: MAJOR.


VERDICT: KILL

(As structured and as marketed. Reasoning, in order of lethality:)

  1. The return engine does not clear the cost of capital under normal conditions. Gross deal IRR is 7.2% at trend-ish 3% HPA with a punctual year-7 exit, decaying to ~5.7-6.1% on realistic exit timing, and ~7.4% NET in the best case cell after any standard fee load. The claimed 11% requires above-trend appreciation plus exit behavior the underwriting deliberately selects against. This is a beta product priced like alpha.

  2. The liquidity thesis is unfalsifiable until it is fatal. The fund's viability depends on a secondary market the spec admits does not exist, that structurally cannot exist before the first fund needs it (seasoning chicken-and-egg), and that on my pricing model delivers ~0-5% originator IRR at trend HPA even if it does appear. Meanwhile the vehicle carries binding 84-month payment obligations with a contractual forfeiture doom-loop if funding falters.

  3. Uncompensated tail risk everywhere: junior, non-recourse, no foreclosure right, extinguished by senior foreclosure, SPECULATIVE bankruptcy treatment, STATE-DEPENDENT recharacterization/usury exposure, AMBIGUOUS tax treatment of the core monthly-payment innovation — and not one basis point of spread, coupon, or premium anywhere in the structure to absorb any of it.

  4. The marketing is materially inconsistent with the spec (Part A: two CRITICAL, ~ten MAJOR divergences, including "guaranteed," "no competing product," "capital preserved," and the $690K arithmetic). In an institutional raise this file is discoverable; it converts business failure into litigation.

Could a fix-before-launch case exist? Only by changing the product into something else: a settlement-dated instrument (defined maturity), a priced spread or premium restoring loss-absorption (which resurrects the debt/tax problem the 1.0x was chosen to avoid — the design is trapped between its tax posture and its economics), a funded and licensed Equity Shield, resolved tax opinion/PLR, and a 15-year evergreen vehicle honestly marketed at ~6-8% net. That is a different, smaller, slower product with no obvious right to win against incumbents who can copy it in a quarter. On the terms actually disclosed and marketed: kill.

--- end of report ---